Flagship explainer

How Collegium Pharmaceutical, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$781M · 100%Cost of revenue$317M · 41%Gross profit$463M · 59%Operating income$180M · 23%Income before tax$92.6M · 12%Income tax$29.7M · 4%Net income$62.9M · 8%As of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$781M100%
Cost of revenue$317M41%
$463M59%
$180M23%
Income before tax$92.6M12%
Income tax$29.7M4%
$62.9M8%
Source: · event Dec 31, 2025 · retrieved Oct 15, 2026 · annual-row source set
Embed this chart

View the full Collegium Pharmaceutical, Inc. analysis at Buy Like Buffett

COLL income explainer — Buy Like Buffett · Buy Like Buffett